Literature DB >> 1851852

Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion.

A Moscona1, R W Peluso.   

Abstract

Cells persistently infected with human parainfluenza virus type 3 (HPF3) exhibit a novel phenotype. They are completely resistant to fusion with each other but readily fuse with uninfected cells. We demonstrate that the inability of these cells to fuse with each other is due to a lack of cell surface neuraminic acid. Neuraminic acid is the receptor for the HPF3 hemagglutinin-neuraminidase (HN) glycoprotein, the molecule responsible for binding of the virus to cell surfaces. Uninfected CV-1 cells were treated with neuraminidase and then tested for their ability to fuse with the persistently infected (pi) cells. Neuraminidase treatment totally abolished cell fusion. To extend this result, we used a cell line deficient in sialic acid and demonstrated that these cells, like the neuraminidase-treated CV-1 cells, were unable to fuse with pi cells. We then tested whether mimicking the agglutinating function of the HN molecule with lectins would result in cell fusion. We added a panel of five lectins to the neuraminic acid-deficient cells and showed that binding of these cells to the pi cells did not result in fusion; the lectins could not substitute for interaction of neuraminic acid with the HN molecule in promoting membrane fusion. These results provide compelling evidence that the HN molecule of HPF3 and its interaction with neuraminic acid participate in membrane fusion and that cell fusion is mediated by an interaction more complex than mere juxtaposition of the cell membranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851852      PMCID: PMC240891     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus.

Authors:  A Portner; R A Scroggs; D W Metzger
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

2.  Selection of lectin-resistant mutants of animal cells.

Authors:  P Stanley
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity.

Authors:  H Shibuta; T Kanda; A Hazama; A Adachi; M Matumoto
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

Review 4.  The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.

Authors:  P W Choppin; A Scheid
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

5.  Human parainfluenza virus type 3: messenger RNAs, polypeptide coding assignments, intergenic sequences, and genetic map.

Authors:  M K Spriggs; P L Collins
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

6.  Syncytium formation by recombinant vaccinia viruses carrying bovine parainfluenza 3 virus envelope protein genes.

Authors:  Y Sakai; H Shibuta
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein.

Authors:  D C Merz; J S Wolinsky
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

8.  Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus.

Authors:  H Shibuta; A Nozawa; T Shioda; T Kanda
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

9.  Immediate persistent infection by human parainfluenza virus 3: unique fusion properties of the persistently infected cells.

Authors:  S L Wechsler; D M Lambert; M S Galinski; M A Mink; O Rochovansky; M W Pons
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

Review 10.  Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.

Authors:  D C Merz; A Scheid; P W Choppin
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  56 in total

1.  Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.

Authors:  R J Hurrelbrink; P C McMinn
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.

Authors:  Anne Moscona; Matteo Porotto; Samantha Palmer; Caroline Tai; Lori Aschenbrenner; Gallen Triana-Baltzer; Qi-Xiang Li; David Wurtman; Stefan Niewiesk; Fang Fang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

3.  Identification of domains on the fusion (F) protein trimer that influence the hemagglutinin-neuraminidase specificity of the f protein in mediating cell-cell fusion.

Authors:  Masato Tsurudome; Morihiro Ito; Machiko Nishio; Mito Nakahashi; Mitsuo Kawano; Hiroshi Komada; Tetsuya Nosaka; Yasuhiko Ito
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  Mechanism of interference mediated by human parainfluenza virus type 3 infection.

Authors:  M A Horga; G L Gusella; O Greengard; N Poltoratskaia; M Porotto; A Moscona
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia.

Authors:  C M Horvath; R G Paterson; M A Shaughnessy; R Wood; R A Lamb
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

7.  Analysis of the fusion protein gene of the porcine rubulavirus LPMV: comparative analysis of paramyxovirus F proteins.

Authors:  M Berg; A C Bergvall; M Svenda; A Sundqvist; J Moreno-López; T Linné
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

8.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.

Authors:  S Bagai; R A Lamb
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Authors:  Santanu Bose; Mausumi Basu; Amiya K Banerjee
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Subacute sclerosing panencephalitis virus dominantly interferes with replication of wild-type measles virus in a mixed infection: implication for viral persistence.

Authors:  A Hirano
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.